Update on nonsmall cell lung cancer
- PMID: 20956190
- PMCID: PMC9487276
- DOI: 10.1183/09059180.00006610
Update on nonsmall cell lung cancer
Conflict of interest statement
G. Zalcman has received fees for speaking, for organising education, and reimbursement for attending international meetings from Lilly- France, Roche-France, GSKbio, AstraZeneca-France, MSD-France, Merck Serrono-France, and for participating in advisory boards from Roche-France, Elli Lilly, GSKbio and BMS.
References
-
- Jemal A, Siegel R, Ward E, et al. . Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225–249. - PubMed
-
- Sant M, Allemani C, Santaquilani M, et al. . EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 2009; 45: 931–991. - PubMed
-
- Devesa SS, Bray F, Vizcaino AP, et al. . International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005; 117: 294–299. - PubMed
-
- Friedel G, Steger V, Kyriss T, et al. . Prognosis in N2 NSCLC. Lung Cancer 2004; 45 Suppl. 2:S45–S53. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical